Jun 18, 2026 09:20AM
Jun 18, 2026 09:20AM
Jun 9, 2026 09:20AM
Jun 9, 2026 09:20AM
Jun 4, 2026 09:15AM
May 20, 2026 04:06PM
May 20, 2026 04:05PM Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
May 13, 2026 04:05PM
May 11, 2026 09:10AM
May 11, 2026 09:10AM
May 8, 2026 04:05PM
May 8, 2026 04:05PM
May 5, 2026 04:15PM
May 4, 2026 07:34AM Longeveron (LGVN) PT Lowered to $8 at H.C. Wainwright
Apr 23, 2026 06:15AM
Apr 8, 2026 09:15AM
Apr 8, 2026 09:15AM
Mar 18, 2026 11:30AM
Mar 17, 2026 04:05PM
Mar 12, 2026 09:00AM
Mar 11, 2026 04:05PM Longeveron closes $15 million private placement with potential $15 million more
Mar 11, 2026 04:05PM
Mar 10, 2026 09:01AM
Mar 10, 2026 09:00AM
Feb 25, 2026 11:05AM
Feb 25, 2026 11:05AM
Feb 13, 2026 04:30PM
Feb 13, 2026 04:30PM Longeveron® Appoints Stephen H. Willard as Chief Executive Officer
Feb 5, 2026 09:15AM
Jan 29, 2026 09:15AM
Jan 29, 2026 09:15AM
Jan 26, 2026 09:15AM
Jan 26, 2026 09:15AM
Dec 29, 2025 09:15AM
Dec 17, 2025 09:15AM Longeveron receives patent for stem cell therapy treating female sexual dysfunction
Dec 17, 2025 09:15AM
Dec 3, 2025 09:15AM
Dec 3, 2025 09:15AM
Dec 2, 2025 09:15AM
Dec 2, 2025 09:15AM
Dec 1, 2025 12:02PM
Dec 1, 2025 12:00PM Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD
Nov 19, 2025 09:15AM
Nov 19, 2025 09:15AM
Nov 12, 2025 09:05AM
Nov 12, 2025 09:05AM
Nov 4, 2025 04:05PM
Oct 28, 2025 09:15AM
Oct 27, 2025 09:15AM Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR’s BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS),
Oct 6, 2025 09:15AM

323,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All